lexiara

2.

The sponsor shall notify each Member State concerned of the end of a clinical trial in all Member States concerned through the EU portal. That notification shall be made within 15 days from the end of the clinical trial in the last Member State concerned.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.